Newly approved drug is a “game changer” for Stage 4 pancreatic cancer patients Central Oregon DailyFDA Approves Drug for Pancreatic Cancer in Milestone for Treatment of Deadly Disease WSJFDA Approves RASONQUE™ (daraxonrasib) Pancreatic Cancer Action NetworkFDA Approves RevMed’s Breakthrough Pill for Pancreatic Cancer Bloomberg.comNew Drug Approved by F.D.A. for Pancreatic Cancer Could Be First of Many The New York Times